Utilizing this approach, Yao et al. (235) identified a tumor immune barrier (TIB) composed of SPP1+ macrophages and cancer-associated fibroblasts (CAFs) near tumor boundaries, influencing immune checkpoint blockade efficacy. The gene discussed is SPP1; the disease is cancer.